a developer of novel therapies for the treatment of retinal disease
Industry Biotechnology
A.I.dvisor indicates that over the last year, KOD has been loosely correlated with CRSP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then CRSP could also see price increases.
Ticker / NAME | Correlation To KOD | 1D Price Change % | ||
---|---|---|---|---|
KOD | 100% | +8.27% | ||
CRSP - KOD | 43% Loosely correlated | -1.85% | ||
RXRX - KOD | 43% Loosely correlated | -3.43% | ||
AVIR - KOD | 42% Loosely correlated | +0.60% | ||
NTLA - KOD | 41% Loosely correlated | -3.24% | ||
BEAM - KOD | 41% Loosely correlated | -1.57% | ||
More |
Ticker / NAME | Correlation To KOD | 1D Price Change % |
---|---|---|
KOD | 100% | +8.27% |
drugs theme (254 stocks) | 48% Loosely correlated | -1.72% |
treatment theme (56 stocks) | 41% Loosely correlated | -1.12% |
biotechnology theme (238 stocks) | 32% Poorly correlated | -1.80% |